Showing results (71-80 of 31,335) with videos related to
Sort By:
Pageof 3,134
Journal of Medicinal Chemistry|October 1, 1990
Antimicrobial properties of N3-(iodoacetyl)-L-2,3-diaminopropanoic acid-peptide conjugatesR Andruszkiewicz, H Chmara, S Milewski, et al.Journal of Medicinal Chemistry|January 6, 2011
Discovery, synthesis, and biological evaluation of a novel group of selective inhibitors of filoviral entryMaria V Yermolina, Jizhen Wang, Michael Caffrey, et al.Journal of Medicinal Chemistry|January 11, 2011
Synthesis and biological evaluation of a new series of 1,2,4-triazolo[1,5-a]-1,3,5-triazines as human A(2A) adenosine receptor antagonists with improved water solubilityStephanie Federico, Silvia Paoletta, Siew Lee Cheong, et al.Journal of Medicinal Chemistry|January 4, 2011
Design and synthesis of potent HIV-1 protease inhibitors incorporating hexahydrofuropyranol-derived high affinity P(2) ligands: structure-activity studies and biological evaluationArun K Ghosh, Bruno D Chapsal, Abigail Baldridge, et al.Journal of Medicinal Chemistry|October 8, 2010
Novel 1',1'-chain substituted hexahydrocannabinols: 9β-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol (AM2389) a highly potent cannabinoid receptor 1 (CB1) agonistSpyros P Nikas, Shakiru O Alapafuja, Ioannis Papanastasiou, et al.Journal of Medicinal Chemistry|October 16, 2010
Synthetic analogues of the microtubule-stabilizing sponge alkaloid ceratamine A are more active than the natural productMatt Nodwell, Carla Zimmerman, Michel Roberge, et al.Journal of Medicinal Chemistry|October 12, 2010
Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndromeAkira Asagarasu, Teruaki Matsui, Hiroyuki Hayashi, et al.Journal of Medicinal Chemistry|October 12, 2010
Sterols as anticancer agents: synthesis of ring-B oxygenated steroids, cytotoxic profile, and comprehensive SAR analysisJoão F S Carvalho, M Manuel Cruz Silva, João N Moreira, et al.Journal of Medicinal Chemistry|October 12, 2010
Discovery of dual inducible/neuronal nitric oxide synthase (iNOS/nNOS) inhibitor development candidate 4-((2-cyclobutyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)-7,8-difluoroquinolin-2(1H)-one (KD7332) part 2: identification of a novel, potent, and selective series of benzimidazole-quinolinone iNOS/nNOS dimerization inhibitors that are orally active in pain modelsJoseph E Payne, Céline Bonnefous, Kent T Symons, et al.Journal of Medicinal Chemistry|October 22, 2010
Indazolylpyrazolopyrimidine as highly potent B-Raf inhibitors with in vivo activityXiaolun Wang, Dan M Berger, Edward J Salaski, et al.Pageof 3,134